In terms of market performance, Protalix BioTherapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $2.76 on 02/06/25, while the lowest value was $0.82 on 08/14/24.
52-week price history of PLX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Protalix BioTherapeutics Inc’s current trading price is -5.43% away from its 52-week high, while its distance from the 52-week low is 217.75%. The stock’s price range for this period has remained between $0.82 and $2.76. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.38 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.69 million over the last three months.
Financial Performance and Market Capitalization
Protalix BioTherapeutics Inc (PLX) has experienced a quarterly rise of 20.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 203.66M and boasts a workforce of 213 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.23, with a change in price of +0.92. Similarly, Protalix BioTherapeutics Inc recorded 608,487 in trading volume during the last 100 days, posting a change of +54.44%.
PLX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PLX stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.09.
PLX Stock Stochastic Average
As of today, the raw stochastic average of Protalix BioTherapeutics Inc over the past 50 days is 76.16%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 90.20%. Additionally, the Stochastic %K and %D values for the company were 90.20% and 86.49%, respectively, over the past 20 days.
PLX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 38.83%. However, over the last six months, the performance has been weaker by 141.67%. The price of PLX increased 16.00% over the last 30 days. And in the last five days, it has surged by 12.99%.
